550 Shares in CVS Health Co. (NYSE:CVS) Bought by Advantage Trust Co

Advantage Trust Co purchased a new position in shares of CVS Health Co. (NYSE:CVS) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 550 shares of the pharmacy operator’s stock, valued at approximately $43,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atticus Wealth Management LLC increased its stake in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in shares of CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 243 shares in the last quarter. ZRC Wealth Management LLC grew its holdings in shares of CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares in the last quarter. Coston McIsaac & Partners increased its position in shares of CVS Health by 42.6% during the fourth quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after acquiring an additional 161 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners bought a new stake in CVS Health during the fourth quarter worth $50,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

Shares of CVS traded up $0.76 during mid-day trading on Thursday, reaching $55.67. 10,298,162 shares of the stock traded hands, compared to its average volume of 11,874,933. The company has a market cap of $69.89 billion, a price-to-earnings ratio of 9.79, a price-to-earnings-growth ratio of 0.88 and a beta of 0.56. CVS Health Co. has a 1 year low of $53.70 and a 1 year high of $83.25. The firm has a fifty day moving average price of $71.54 and a 200 day moving average price of $72.96. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.20 EPS. As a group, equities research analysts predict that CVS Health Co. will post 7.03 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 4.78%. CVS Health’s dividend payout ratio is presently 46.75%.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent analyst reports. The Goldman Sachs Group lowered their target price on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. StockNews.com downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Barclays lowered their price target on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, May 2nd. Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Finally, UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $85.00 to $60.00 in a research note on Thursday, May 2nd. Nine investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $76.75.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction dated Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.